Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Douce

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Thorax|August 24, 1999
Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthmaA J Fairfax, V David, G Douce
International Archives of Allergy and Immunology|December 1, 1995
Genetic detoxification of bacterial toxins: a new approach to vaccine developmentR Rappuoli, G Douce, G Dougan, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
New vaccines against bacterial toxinsR Rappuoli, M Pizza, G Douce, et al.
Immunology Today|October 26, 1999
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxinsR Rappuoli, M Pizza, G Douce, et al.
Vaccine|October 24, 2001
A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC)R Stratford, G Douce, F Bowe, et al.
The Veterinary Record|May 20, 1978
German shepherds and splenic tumorsE C Appleby, A H Hayward, G Douce
Infection and Immunity|July 1, 1997
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxinG Douce, M Fontana, M Pizza, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteersP O'Neill, K Nye, G Douce, et al.
Infection and Immunity|September 25, 1999
Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficileS J Ward, G Douce, G Dougan, et al.
Infection and Immunity|May 4, 1999
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin AS J Ward, G Douce, D Figueiredo, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Thorax|August 24, 1999
Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthmaA J Fairfax, V David, G Douce
International Archives of Allergy and Immunology|December 1, 1995
Genetic detoxification of bacterial toxins: a new approach to vaccine developmentR Rappuoli, G Douce, G Dougan, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
New vaccines against bacterial toxinsR Rappuoli, M Pizza, G Douce, et al.
Immunology Today|October 26, 1999
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxinsR Rappuoli, M Pizza, G Douce, et al.
Vaccine|October 24, 2001
A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC)R Stratford, G Douce, F Bowe, et al.
The Veterinary Record|May 20, 1978
German shepherds and splenic tumorsE C Appleby, A H Hayward, G Douce
Infection and Immunity|July 1, 1997
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxinG Douce, M Fontana, M Pizza, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteersP O'Neill, K Nye, G Douce, et al.
Infection and Immunity|September 25, 1999
Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficileS J Ward, G Douce, G Dougan, et al.
Infection and Immunity|May 4, 1999
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin AS J Ward, G Douce, D Figueiredo, et al.
Pageof 4